Kumra's product pipeline represents a diversified range of products across multiple therapeutic areas and dosage forms, including a sizeable proportion of complex, high barrier to entry and difficult to formulate products. It has expertise in topicals, inhalers, oral liquids, oral solids, opthalimic solutions, device driven products, transdermals and injectables. The company's portfolio now includes more than 450 generics.

Kumras product pipeline hosts broad coverage of therapeutic areas such as cardiovascular, central nervous system, pain, oncology, inflammation, anti infective, dermatology, endocrinology, diabetes, rhinology, urology and haematology to name a few.